A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody ; volume:8 ; number:1 ; day:12 ; month:3 ; year:2018 ; pages:1-15 ; date:12.2018
Scientific reports ; 8, Heft 1 (12.3.2018), 1-15, 12.2018

Creator: Nogales, Aitor

Contributor: Piepenbrink, Michael S.
Wang, Jiong
Ortega, Sandra
Basu, Madhubanti
Fucile, Christopher F.
Treanor, John J.
Rosenberg, Alexander F.
Zand, Martin S.
Keefer, Michael C.
Martinez-Sobrido, Luis
Kobie, James J.
SpringerLink (Online service)

DOI: 10.1038/s41598-018-22307-8

URN: urn:nbn:de:1111-201805125490

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Nogales, Aitor
Piepenbrink, Michael S.
Wang, Jiong
Ortega, Sandra
Basu, Madhubanti
Fucile, Christopher F.
Treanor, John J.
Rosenberg, Alexander F.
Zand, Martin S.
Keefer, Michael C.
Martinez-Sobrido, Luis
Kobie, James J.
SpringerLink (Online service)

Other Objects (12)

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques

Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination

A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets

Broadly Neutralizing Antibodies for HIV Eradication

Novel computational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies

Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1

Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques

Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination

A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets

Broadly Neutralizing Antibodies for HIV Eradication

Novel computational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies

Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1

Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques

Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination

A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets

Broadly Neutralizing Antibodies for HIV Eradication

Novel computational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies

Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1

Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques

Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination

A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets

Broadly Neutralizing Antibodies for HIV Eradication

Novel computational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies

Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1

Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques

Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination

A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets

Broadly Neutralizing Antibodies for HIV Eradication

Novel computational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies

Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1

Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques

Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination

A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets

Broadly Neutralizing Antibodies for HIV Eradication

Novel computational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies

Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1

Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates

Related objects

Reset password